2. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. 2007; Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 7:34. DOI:
10.1186/1471-230X-7-34. PMID:
17697371. PMCID:
PMC1976099.
3. Song SH, Seo KH, Kim JH, et al. 1999; A case of obstructive jaundice caused by cavernous transformation of the portal vein. Clin Endosc. 19:999–1004.
5. Shin SM, Kim S, Lee JW, et al. 2005; Magnetic resonance imaging findings of portal biliopathy. J Korean Soc Radiol. 52:123–132. DOI:
10.3348/jkrs.2005.52.2.123.
6. Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. 2008; Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 28:1115–1129. DOI:
10.1148/rg.284075148. PMID:
18635632.
7. Clayton RA, Clarke DL, Currie EJ, Madhavan KK, Parks RW, Garden OJ. 2003; Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon. 1:32–38. DOI:
10.1016/S1479-666X(03)80006-9. PMID:
15568422.
8. Stewart CJ, Mills PR, Carter R, et al. 2001; Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol. 54:449–455. DOI:
10.1136/jcp.54.6.449. PMID:
11376018. PMCID:
PMC1731449.
9. Yoon SB, Moon SH, Ko SW, Lim H, Kang HS, Kim JH. Brush cytology, forceps biopsy, or endoscopic ultrasound-guided sampling for diagnosis of bile duct cancer: a meta-analysis. Dig Dis Sci. 2021; Jul. 14. [Epub ahead of print]. DOI:
10.1007/s10620-021-07138-4. PMID:
34263382.
10. Jeon TY, Choi MH, Yoon SB, Soh JS, Moon SH. 2022; Systematic review and meta-analysis of percutaneous transluminal forceps biopsy for diagnosing malignant biliary strictures. Eur Radiol. 32:1747–1756. DOI:
10.1007/s00330-021-08301-1. PMID:
34537877.
11. Manzano-Robleda Mdel C, Barranco-Fragoso B, Uribe M, Méndez-Sánchez N. 2015; Portal vein thrombosis: what is new? Ann Hepatol. 14:20–27. DOI:
10.1016/s1665-2681(19)30797-5. PMID:
25536638.
12. Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. 2016; Therapeutic approaches for portal biliopathy: a systematic review. World J Gastroenterol. 22:9909–9920. DOI:
10.3748/wjg.v22.i45.9909. PMID:
28018098. PMCID:
PMC5143758.
13. Kim S, Yun YM, Kim IS, et al. 2016; Clinical pharmacogenetic testing and application: laboratory medicine clinical practice guidelines part 2. Lab Med Online. 6:193–213. DOI:
10.3343/lmo.2016.6.4.193.
14. Kim JS, Kim BW. 2018; Management of patients on antithrombotic agents undergoing endoscopy. Korean J Gastroenterol. 71:282–285. DOI:
10.4166/kjg.2018.71.5.282. PMID:
29791987.
15. Gallego C, Velasco M, Marcuello P, Tejedor D, De Campo L, Friera A. 2002; Congenital and acquired anomalies of the portal venous system. Radiographics. 22:141–159. DOI:
10.1148/radiographics.22.1.g02ja08141. PMID:
11796904.
16. Corvera CU, Blumgart LH, Darvishian F, et al. 2005; Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 201:862–869. DOI:
10.1016/j.jamcollsurg.2005.07.011. PMID:
16310689.
17. Wakai T, Shirai Y, Sakata J, et al. 2012; Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg. 78:1388–1391. DOI:
10.1177/000313481207801232. PMID:
23265129.
18. Roos E, Hubers LM, Coelen RJS, et al. 2018; IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience. Am J Gastroenterol. 113:765–772. DOI:
10.1038/s41395-018-0036-5. PMID:
29549357.